Panic Disorders Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Report Code: ZMR-1505 | Report Format : | Status : Upcoming |

Abstract

Global Panic Disorders Market: Overview

When a patient suffers from frequent sudden panic attacks then that patient is suffering from the panic disorder which is a type of anxiety disorder. The patient has the following symptoms when panic attacks occur such as intense fear, sweating, shortness of breath, palpitations, shaking, numbness, etc. The reason or the cause for the panic attack is anonymous.

Global Panic Disorders Market: Segmentation

The panic disorder market is globally segmented into its type, drug class, and regions. On the basis of type, the global market is segregated into agoraphobia, social anxiety disorder (SAD), obsessive-compulsive disorder (OCD), bipolar disorder, post-traumatic stress disorder (PTSD), specific phobias, generalized anxiety disorder (GAD), and major depressive disorder. Based on the drug class, the market is categorized into selective serotonin reuptake inhibitor (SSRI), benzodiazepines (BZD), and serotonin-norepinephrine reuptake inhibitor (SNRI). The selective serotonin reuptake inhibitor (SSRI) is further sub-segmented into paroxetine (Paxil, Pexeva), fluoxetine (Prozac), and sertraline (Zoloft).

Global Panic Disorders Market: Growth Factors

The increasing awareness regarding the disorders, growing prevalence of the mental and anxiety disorders, and the availability of treatment options that are effective are some of the key factors that estimate to fuel the growth of the global panic disorders market. The increasing initiatives that are being taken by the leading players in order to create an understanding among the consumers will accelerate the growth of the market. In the recent years, several drugs are in different phases of clinical trials, which will be commercialized soon thus encouraging the growth of the market. On the other hand, in underdeveloped and developing economies there is a lack of awareness regarding the severity of these disorders if not treated is the major factor that is likely to restrict the overall growth of the market in the coming years.

Global Panic Disorders Market: Regional Analysis

North America predicts to lead the global panic disorders market and hold a huge share in the global market. The high growth in this region can be attributed to the factors such as the presence of a large number of players that are involved in this field and the increasing awareness among the consumers regarding the accessibility of the therapeutics that are effective for the panic disorders. Europe expects to remain in the second position. Asia Pacific projects witnessing robust growth in the coming years, owing to the unexploited lucrative opportunities for the key players. In addition, the expanding purchasing capacity of the consumers in the region expects to encourage the growth of the market. India and China anticipate contributing considerably towards the growth of the panic disorders market in Asia Pacific region.

Global Panic Disorders Market: Competitive Players

Some of the key market players that are involved in the panic disorders market include Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH., GlaxoSmithKline Plc., F. Hoffmann-La Roche Ltd., Valeant Pharmaceuticals International, Inc., Pfizer, Inc., H. Lundbeck A/S, Actavis Plc., Sanofi, Eli Lilly and Company, Neurocrine Biosciences, Inc., Mylan, Inc., and AstraZeneca Plc.

Global Panic Disorders Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Related Reports

Animal Model Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2478 | Report Format:

Animal Model Market: Overview The animal in which the pathological and the biological studies are done and tested such animal is referred as an animal model. The animal models are used as it has a functional resemblance to the human body. There are various guidelines that have to be followed whi...Read More

Vulvodynia Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2437 | Report Format:

Vulvodynia Treatment Market: Overview The condition where there is constant pain and discomfort being experienced in the opening of the vulva then it is termed as vulvodynia. What causes this problem is not recognized. This condition affects the womens life by making it difficult to exercise, se...Read More

Endocrine Peptides Test Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2435 | Report Format:

Endocrine Peptides Test Market: Overview In order to measure the level of the c-peptide that is present in the blood the endocrine peptide test is conducted. In the normal case, the amount of the insulin and the c-peptide are found at the equal level. Insulin helps in the regulation of the gluco...Read More

Helicobacter Pylori Testing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2433 | Report Format:

Helicobacter Pylori Testing Market: Overview The test that is done for identifying the Helicobacter pylori infection in the upper part of the small intestine and the stomach the Helicobacter pylori testing is used. With the help of the Helicobacter pylori test, one can also determine the effecti...Read More

Retrovirus Testing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2403 | Report Format:

Retrovirus Testing Market: Overview Retrovirus consists of an enzyme known as the reverse transcriptase in the single-stranded RNA virus. It is with the help of the reverse transcriptase that the retroviral RNA gets transcribed into the retroviral DNA after it enters the host cell. Retrovirus ...Read More

year end sale
Choose License Type:
Latest Published Reports

View All Published Reports